Litcius/Paper detail

Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa

Ingrid J.G. Burvenich, Yit Wooi Goh, Nancy Guo, Hui Gan, Angela Rigopoulos, Diana Cao, Zhanqi Liu, Uwe Ackermann, Christian Wichmann, Alexander Franklin McDonald, Nhi Huynh, Graeme O’Keefe, Sylvia Gong, Fiona E. Scott, Linghui Li, Wanping Geng, Anup Zutshi, Lan Yan, Andrew M. Scott

2021European Journal of Nuclear Medicine and Molecular Imaging25 citationsDOI

Topics & Concepts

BiodistributionAvelumabIn vivoAntibodyChemistryIsotypeIn vitroFusion proteinMedicinePharmacologyImmunotherapyMonoclonal antibodyImmune systemImmunologyRecombinant DNABiochemistryBiologyPembrolizumabGeneBiotechnologyCancer Immunotherapy and BiomarkersRadiopharmaceutical Chemistry and ApplicationsPeptidase Inhibition and Analysis
Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa | Litcius